Vogenx Inc (VOGX) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. In the last 30 days Quantisnow tracked 3 wire items for VOGX, including 2 SEC filings and 1 market update. The most recent was published Nov 6, 2026.
News · 26 weeks3+100%
2026-05-102026-11-01
Mix390d
- SEC Filings2(67%)
- Market1(33%)
Activity · 52 weeks31 active day
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
3 items- SECSEC Form 10-Q filed by Vogenx Inc10-Q - Vogenx, Inc. (0001903784) (Filer)
- SECVogenx Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Vogenx, Inc. (0001903784) (Filer)
- NEWSVogenx Reports Third Quarter 2026 Financial Results and Business HighlightsAdvances PBH Development Program Following August 2026 Initial Public OfferingStrengthens Balance Sheet with $82.1 Million in Total Cash, Cash Equivalents, and Marketable Securities RALEIGH, NC / ACCESS Newswire / November 6, 2026 / Vogenx, Inc. (NASDAQ:VOGX), a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases, today announced its financial results for the third quarter and provided a corporate update."Our third quarter performance marks a pivotal milestone for Vogenx following our successful public listing in August," said James Green, Chief Executive Officer of Vogenx. "The EMERGE study is now up and running and we ha
VOGX FAQ
7 questionsWhat does Vogenx Inc do?
Vogenx, Inc. (Nasdaq:VOGX) is a clinical-stage biopharmaceutical company based in Raleigh, North Carolina, focused on the discovery and development of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases with high unmet medical need. The Company is developing its lead product candidate, mizagliflozin, for post-bariatric hypoglycemia, gastroparesis and GIP-dependent Cushing's Syndrome.What is the latest news on VOGX?
In the last 30 days Quantisnow tracked 3 wire items for VOGX: 2 SEC filings and 1 market update. The most recent was published on November 6, 2026.Where does VOGX stock trade?
Vogenx Inc (VOGX) is listed on NASDAQ.What sector and industry is VOGX in?
Vogenx Inc operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Vogenx Inc go public?
Vogenx Inc (VOGX) completed its IPO in 2026.What companies are similar to VOGX?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare VOGX side-by-side with any of them on Quantisnow.How can I track VOGX on Quantisnow?
Quantisnow aggregates Vogenx Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VOGX to receive live email and push alerts on every new disclosure.